Abstract
Chemokine-glycosaminoglycan (GAG) interactions have been shown to be essential for in vivo chemokine signaling, which functions in such diverse processes as inflammation, development, and cancer metastasis. Despite the importance of these interactions, the saccharide sequence dependency of chemokine-GAG interactions is poorly understood. In a recent study, FT-ICR mass spectrometry was used to show that the chemokine CCL2 (monocyte chemoattractant protein 1) binds only to the 11- and 12-sulfated components of a heparin octasaccharide library. Although the exact structure of the fully sulfated, 12-sulfated octasaccharide is known, the 11-sulfated species could have a number of sulfated disaccharide sequences. In the current study, the composition of the 11-sulfated heparin octasaccharides, as well as the composition of CCL2 affinity purified 11-sulfated heparin octasaccharides, were examined by tandem MS. Of the three possible singly desulfated disaccharides, one species, III-S, is enriched by CCL2 affinity purification, indicating that the 11-sulfated heparin octasaccharides containing this disaccharide are preferentially bound to CCL2. These data suggest that 2-O and N sulfation of heparin may be of greater importance to CCL2-heparin binding than 6-O sulfation.
Article PDF
Avoid common mistakes on your manuscript.
References
Rot, A. Endothelial cell binding of NAP-1/IL-8: Role in neutrophil emigration. Immunol. Today. 1992, 13, 291–294.
Handel, T. M.; Johnson, Z.; Crown, S. E.; Lau, E. K.; Sweeney, M.; Proudfoot, A. E. Regulation of protein function by glycosaminoglycans—as exemplified by chemokines. Annu. Rev. Biochem. 2005, 74, 385–410.
Lau, E. K.; Paavola, C. D.; Johnson, Z.; Gaudry, J. P.; Geretti, E.; Borlat, F.; Kungl, A. J.; Proudfoot, A. E.; Handel, T. M. Identification of the glycosaminoglycan binding site of the CC chemokine, MCP-1: Iimplications for structure and function in vivo. J. Biol. Chem. 2004, 279, 22294–22305.
Proudfoot, A. E.; Handel, T. M.; Johnson, Z.; Lau, E. K.; LiWang, P.; Clark-Lewis, I.; Borlat, F.; Wells, T. N. C.; Kosco-Vilbois, M. H. Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 1885–1890.
Middleton, J.; Neil, S.; Wintle, J.; Clark-Lewis, I.; Moore, H.; Lam, C.; Auer, M.; Hub, E.; Rot, A. Transcytosis and surface presentation of IL-8 by venular endothelial cells. Cell. 1997, 91, 385–395.
Saad, O. M.; Ebel, H.; Uchimura, K.; Rosen, S. D.; Bertozzi, C. R.; Leary, J. A. Compositional profiling of heparin/heparan sulfate using mass spectrometry: Assay for specificity of a novel extracellular human endosulfatase. Glycobiology. 2005, 15, 818–826.
Ashikari-Hada, S.; Habuchi, H.; Kariya, Y.; Itoh, N.; Reddi, A. H.; Kimata, K. Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. J. Biol. Chem. 2004, 279, 12346–12354.
Kreuger, J.; Jemth, P.; Sanders-Lindberg, E.; Eliahu, L.; Ron, D.; Basilico, C.; Salmivirta, M.; Lindahl, U. Fibroblast growth factors share binding sites in heparan sulphate. Biochem. J. 2005, 389, 145–150.
Mohammadi, M.; Olsen, S. K.; Goetz, R. A protein canyon in the FGF-FGF receptor dimer selects from an a la carte menu of heparan sulfate motifs. Curr. Opin. Struct. Biol. 2005, 15, 506–516.
Jin, L.; Abrahams, J. P.; Skinner, R.; Petitou, M.; Pike, R. N.; Carrell, R. W. The anticoagulant activation of antithrombin by heparin. Proc. Natl. Acad. Sci. U.S.A. 1997, 94, 4683–14688.
Whisstock, J. C.; Pike, R. N.; Jin, L.; Skinner, R.; Pei, Y. X.; Carrell, R. W.; Lesk, R. M. Conformational changes in serpins: II. the mechanism of activation of antithrombin by heparin. J. Mol. Biol. 2000, 301, 1287–1305.
Shukla, D.; Liu, J.; Blaiklock, P.; Shworak, N. W.; Bai, X.; Esko, J. D.; Cohen, G. H.; Eisenberg, R. J.; Rosenberg, R. D.; Spear, P. G. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell. 1999, 99, 13–22.
Yu, Y.; Sweeney, M. D.; Saad, O. M.; Crown, S. E.; Handel, T. M.; Leary, J. A. Chemokine-glycosaminoglycan binding: specificity for CCR2 ligand binding to highly sulfated oligosaccharides using FTICR mass spectrometry. J. Biol. Chem. 2005, 280, 32200–32208.
Stringer, S. E.; Gallagher, J. T. Heparan sulphate. Int. J. Biochem. Cell Biol. 1997, 29, 709–714.
Stringer, S. E.; Gallagher, J. T. Specific binding of the chemokine platelet factor 4 to heparan sulfate. J. Biol. Chem. 1997, 33, 20508–20514.
Spillmann, D.; Witt, D.; Lindahl, U. Defining the interleukin-8-binding domain of heparan sulfate. J. Biol. Chem. 1998, 273, 15487–15493.
Stringer, S. E.; Forster, M. J.; Mulloy, B.; Bishop, C. R.; Graham, G. J.; Gallagher, J. T. Characterization of the binding site on heparan sulfate for macrophage inflammatory protein 1α. Blood. 2002, 100, 1543–1550.
Linhardt, R. J.; Turnbull, J. E.; Wang, H. M.; Loganathan, D.; Gallagher, J. T. Examination of the substrate specificity of heparin and heparan sulfate lyases. Biochemistry. 1990, 29, 2611–2817.
Yamada, S.; Murakami, T.; Tsuda, H.; Yoshida, K.; Sugahara, K. Isolation of the Porcine Heparin Tetrasaccharides with Glucuronate 2-O-Sulfate. J. Biol. Chem. 1995, 270, 8696–8705.
Zaia, J.; Costello, C. E. Tandem mass spectrometry of sulfated heparin-like glycosaminoglycan oligosaccharides. Anal. Chem. 2003, 75, 2445–2455.
Laremore, N. L.; Murugensan, S.; Park, T.; Avci, F. Y.; Zagorevski, D. V.; Linhardt, R. J. Matrix-assisted laser desorption/ionization mass spectrometric analysis of uncomplexed highly sulfated oligosaccharides using ionic liquid matrices. Anal. Chem. 2006, 78, 1774–1779.
Behr, J. R.; Matsumoto, Y.; White, F. M.; Sasisekharan, R. Quantification of isomers from a mixture of twelve heparin and heparan sulfate disaccharides using tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2005, 19, 2553–2562.
Henriksen, J.; Roepstorff, P.; Ringborg, L. H. Ion-pairing reversed-phase chromatography/mass spectrometry of heparin. Carbohydr. Res. 2006, 341, 382–287.
Hitchcock, A. M.; Costello, C. E.; Zaia, J. Glycoform quantification of chondroitin/dermatan sulfate using a liquid chromatography-tandem mass spectrometry platform. Biochemistry. 2006, 45, 2350–2361.
Saad, O. M.; Leary, J. A. Heparin sequencing using enzymatic digestion and ESI-MSn with HOST: A heparin/HS oligosaccharide sequencing tool. Anal. Chem. 2005, 77, 5902–5911.
Wu, Z. L.; Lech, M.; Beeler, D. L.; Rosenburg, R. D. Determining heparan sulfate structure in the vicinity of specific sulfotransferase recognition by mass spectrometry. J. Biol. Chem. 2004, 279, 1861–1866.
Desai, U. R.; Wang, H. M.; Linhardt, R. J. Specificity studies on the heparin lyases from flavobacterium-heparinum. Biochemistry. 1993, 32, 8140–8145.
Paavola, C. D.; Hemmerich, S.; Grunberger, D.; Polsky, I.; Bloom, A.; Freedman, R.; Mulkins, M.; Bhakta, S.; McCarley, D.; Wiesent, L.; Wong, B.; Jarnagin, K.; Handel, M. Monomeric monocyte chemoattractant protein-1 (MCP-1) binds and activates the MCP-1 receptor CCR2B. J. Biol. Chem. 1998, 273, 33157–33165.
Saad, O. M.; Leary, J. A. Compositional analysis and quantification of heparin and heparan sulfate by electrospray ionization ion trap mass spectrometry. Anal. Chem. 2003, 75, 2985–2995.
Lubkowski, J.; Bujacz, G.; Boque, L.; Domaille, P. J.; Handel, T. M.; Wlodawer, A. The structure of MCP-1 in two crystal forms provides a rare example of variable quaternary interactions. Nat. Struct. Biol. 1997, 4, 64–69.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published online June 5, 2006
Rights and permissions
About this article
Cite this article
Sweeney, M.D., Yu, Y. & Leary, J.A. Effects of sulfate position on heparin octasaccharide binding to CCL2 examined by tandem mass spectrometry. The official journal of The American Society for Mass Spectrometry 17, 1114–1119 (2006). https://doi.org/10.1016/j.jasms.2006.04.025
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.jasms.2006.04.025